140 related articles for article (PubMed ID: 1680497)
1. T-cell malignancies with mature phenotypes: altered cell cycle regulation by HLA class I molecules.
Turco MC; Alfinito F; De Felice M; Lamberti A; Ferrone S; Venuta S
Blood; 1991 Oct; 78(8):2045-52. PubMed ID: 1680497
[TBL] [Abstract][Full Text] [Related]
2. Mitogenic activity of anti-CD28 MoAb CLB-CD28/1 on peripheral blood mononuclear cells and its cooperation with other anti-T cells MoAb in the activation of purified T lymphocytes.
De Felice M; Giarrusso PC; Lamberti A; Turco MC; Valerio G; van Lier RA; Yang SY; Ferrone S; Venuta S
Tissue Antigens; 1990 Jul; 36(1):12-8. PubMed ID: 1701062
[TBL] [Abstract][Full Text] [Related]
3. Lack of a role of monocytes in the inhibition by monoclonal antibodies to monomorphic and polymorphic determinants of HLA class I antigens of PHA-P-induced peripheral blood mononuclear cell proliferation.
De Felice M; Turco MC; Corbo L; Carandente Giarrusso P; Lamberti A; Valerio G; Temponi M; Costanzo F; Ferrone S; Venuta S
Cell Immunol; 1989 Aug; 122(1):164-77. PubMed ID: 2473845
[TBL] [Abstract][Full Text] [Related]
4. Proliferative pathways in CD1- CD3+ CD4+ CD8+ T-prolymphocytic leukemic cells: analysis with monoclonal antibodies and cytokines.
Turco MC; De Felice M; Alfinito F; Lamberti A; Costanzo F; Giordano M; Martinelli V; Rotoli B; Ferrone S; Venuta S
Blood; 1989 Oct; 74(5):1651-7. PubMed ID: 2790191
[TBL] [Abstract][Full Text] [Related]
5. Signal requirements for activation of leukaemic T cells from a chronic lymphocytic leukaemia (T-CLL).
Zocchi MR; Poggi A; Heltai S; Villa A; Inverardi L; Vicari A; Sabbadini MG; Ferrarini M
Clin Exp Immunol; 1990 Oct; 82(1):108-13. PubMed ID: 1976463
[TBL] [Abstract][Full Text] [Related]
6. Activation of peripheral CD8+ T lymphocytes via CD28 plus CD2: evidence for IL-2 gene transcription mediated by CD28 activation.
Carabasi MH; DiSanto JP; Yang SY; Dupont B
Tissue Antigens; 1991 Jan; 37(1):26-32. PubMed ID: 1676547
[TBL] [Abstract][Full Text] [Related]
7. The required interaction between monocytes and peripheral blood T lymphocytes (T-PBL) upon activation via CD2 or CD3. Role of HLA class I molecules from accessory cells and the differential response of T-PBL subsets.
Huet S; Boumsell L; Dausset J; Degos L; Bernard A
Eur J Immunol; 1988 Aug; 18(8):1187-94. PubMed ID: 2901355
[TBL] [Abstract][Full Text] [Related]
8. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
Wacholtz MC; Patel SS; Lipsky PE
J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
[TBL] [Abstract][Full Text] [Related]
9. CD3 pathway of T-cell activation. II. Role of HLA-class I molecules in early events.
Schwab R; Weksler ME; Russo C
Cell Immunol; 1988 Sep; 115(2):310-24. PubMed ID: 2457448
[TBL] [Abstract][Full Text] [Related]
10. Regulatory role of the CD8 antigen in both CD3 and CD2 monoclonal antibody-induced nonspecific cytotoxicity of class I- and class II-allospecific cytotoxic T cell clones.
Van Seventer GA; Van Lier RA; Kuijpers KC; Spits H; Melief CJ
Eur J Immunol; 1988 Dec; 18(12):1973-8. PubMed ID: 2905994
[TBL] [Abstract][Full Text] [Related]
11. A novel model for antigen-dependent activation of normal human T cells. Transmembrane signaling by crosslinkage of the CD3/T cell receptor-alpha/beta complex with the cluster determinant 2 antigen.
Suthanthiran M
J Exp Med; 1990 Jun; 171(6):1965-79. PubMed ID: 1972176
[TBL] [Abstract][Full Text] [Related]
12. The natural killer-related receptor for HLA-C expressed on T cells from CD3+ lymphoproliferative disease of granular lymphocytes displays either inhibitory or stimulatory function.
Cambiaggi A; Orengo AM; Meazza R; Sforzini S; Tazzari PL; Lauria F; Raspadori D; Zambello R; Semenzato G; Moretta L; Ferrini S
Blood; 1996 Mar; 87(6):2369-75. PubMed ID: 8630400
[TBL] [Abstract][Full Text] [Related]
13. Crosslinking CD3 with CD2 using sepharose-immobilized antibodies enhances T lymphocyte proliferation.
Anderson P; Blue ML; Morimoto C; Schlossman SF
Cell Immunol; 1988 Sep; 115(2):246-56. PubMed ID: 2900689
[TBL] [Abstract][Full Text] [Related]
14. In vitro inhibition of normal human hematopoiesis by marrow CD3+, CD8+, HLA-DR+, HNK1+ lymphocytes.
Vinci G; Vernant JP; Nakazawa M; Zohair M; Katz A; Henri A; Rochant H; Breton-Gorius J; Vainchenker W
Blood; 1988 Nov; 72(5):1616-21. PubMed ID: 2972326
[TBL] [Abstract][Full Text] [Related]
15. Detection of hyperreactive T cells in multiple myeloma by multivalent cross-linking of the CD3/TCR complex.
Massaia M; Bianchi A; Attisano C; Peola S; Redoglia V; Dianzani U; Pileri A
Blood; 1991 Oct; 78(7):1770-80. PubMed ID: 1832993
[TBL] [Abstract][Full Text] [Related]
16. Activation of T lymphocytes via monoclonal antibodies against rat cell surface antigens with particular reference to CD2 antigen.
Beyers AD; Barclay AN; Law DA; He Q; Williams AF
Immunol Rev; 1989 Oct; 111():59-77. PubMed ID: 2576418
[TBL] [Abstract][Full Text] [Related]
17. Role of monocytes in anti-CD3-induced T-cell DNA synthesis: effect of chloroquine and monensin on anti-CD3-induced human T-cell activation.
Vayuvegula B; Ohira K; Gollapudi S; Gupta S
J Clin Immunol; 1990 Sep; 10(5):247-54. PubMed ID: 2148320
[TBL] [Abstract][Full Text] [Related]
18. Role in T-cell activation for HLA class I molecules from accessory cells: further distinction between activation signals delivered to T cells via CD2 and CD3 molecules.
Huet S; Boumsell L; Raynal B; Degos L; Dausset J; Bernard A
Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7222-6. PubMed ID: 3118361
[TBL] [Abstract][Full Text] [Related]
19. Activation of human T lymphocytes through CD3 and CD2 (T11) with anti-CD3-coupled sheep erythrocytes.
Ocklind G
Scand J Immunol; 1988 May; 27(5):609-13. PubMed ID: 2897712
[TBL] [Abstract][Full Text] [Related]
20. Enhancing effect of anti-HLA class I monoclonal antibodies on T cell proliferation induced via CD2 molecule.
Turco MC; de Felice M; Corbo L; Giarrusso PC; Yang SY; Ferrone S; Venuta S
J Immunol; 1988 Oct; 141(7):2275-81. PubMed ID: 3262654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
